FDA updates labeling for MS CONTIN
Labeling changes approved for PURDUE PHARMA LP. Active ingredient: MORPHINE SULFATE. Decision date: 12/22/2025
Labeling changes approved for PURDUE PHARMA LP. Active ingredient: MORPHINE SULFATE. Decision date: 12/22/2025
There are no comments here yet...